Applying to dermatology residency during the COVID-19 pandemic - 08/09/20
Doi : 10.1016/j.jaad.2020.07.011
Donovan G. Kearns, BA a, Vipawee S. Chat, BS b, Shelley Uppal, MD c, Jashin J. Wu, MD d, ⁎ 
a Loma Linda University School of Medicine, California
b Medical College of Georgia at Augusta University, California
c Albany Medical College, New York
d Dermatology Research and Education Foundation, Irvine, California
∗Correspondence to: Jashin J. Wu, MD
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
| Funding sources: None. |
|
| Conflicts of interest: The corresponding stated the authors had no relevant conflicts of interest for this letter. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 4
P. 1214-1215 - octobre 2020 Retour au numéro
Article précédent
- Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study
- Jorge R. Georgakopoulos, Asfandyar Mufti, Ron Vender, Jensen Yeung
- Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy
- Zachary E. Holcomb, Monica Rosales Santillan, Peyton C. Morss-Walton, Prerna Salian, Min Ji Her, Nicole M. Giannotti, Alexa B. Kimball, Martina L. Porter
Bienvenue sur EM-consulte, la référence des professionnels de santé.